NCT00390819

Brief Summary

Pneumonia in general and CAP in particular is considered as one of the most common bacterial infections, associated with high rates of morbidity and mortality and is highly significant economically since all respiratory infections, and pneumonia especially, cause about 80% of antimicrobials use in the community. The high frequency of respiratory infections and the excessive use of antimicrobials are major contributors to the development of pathogens resistant to antimicrobials. In addition, in CAP almost all patients are treated empirically, without identification of causing pathogen. Aim of study: To identify common pathogens causing CAP in hospitalized patients in north Israel.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 20, 2006

Completed
12 days until next milestone

Study Start

First participant enrolled

November 1, 2006

Completed
Last Updated

October 20, 2006

Status Verified

October 1, 2006

First QC Date

October 19, 2006

Last Update Submit

October 19, 2006

Conditions

Community Acquired Pneumonia

Keywords

Community acquired pneumonia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Community acquired pneumonia
  • Hospitalization

You may not qualify if:

  • Immunocompromised patients
  • Patients under chemotherapy treatment
  • Patients under steroids treament

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ha'Emek Medical Center

Afula, 18101, Israel

Location

Related Publications (1)

  • Porath A, Schlaeffer F, Lieberman D. The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect. 1997 Jan;34(1):41-8. doi: 10.1016/s0163-4453(97)80008-4.

    PMID: 9120323BACKGROUND

MeSH Terms

Conditions

Community-Acquired Pneumonia

Condition Hierarchy (Ancestors)

Community-Acquired InfectionsInfectionsPneumoniaRespiratory Tract InfectionsRespiratory Tract Diseases

Study Officials

  • Fahmi Shibli, M.D.

    Ha'Emek Medical Center, Afula, Israel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fahmi Shibli, M.D.

CONTACT

972-4-6494000fahmi_shibli@yahoo.ie

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 19, 2006

First Posted

October 20, 2006

Study Start

November 1, 2006

Last Updated

October 20, 2006

Record last verified: 2006-10

Locations

IL(1)